Status:
COMPLETED
ColoAssist vs. MEI
Lead Sponsor:
Sorlandet Hospital HF
Conditions:
Colorectal Cancer
Screening
Eligibility:
All Genders
55-66 years
Phase:
NA
Brief Summary
Colonoscopy aims to investigate the entire colon by advancing the colonoscope tip from the rectum to the cecum, a process called cecal intubation. Cecal intubation may be difficult for different reaso...
Detailed Description
The recommended cecal intubation rate in colorectal cancer (CRC) screening is 95%. The MEI system allows real time monitoring of the colonoscope position within the colon and is considered to be a use...
Eligibility Criteria
Inclusion
- Inclusion in an ongoing colorectal cancer screening trial (NCT 00883792)
Exclusion
- Excluded from the ongoing screening trial (NCT 00883792)
- Inability or unwilling to provide informed consent
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2014
Estimated Enrollment :
475 Patients enrolled
Trial Details
Trial ID
NCT01895504
Start Date
April 1 2013
End Date
July 1 2014
Last Update
March 4 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
SSHF Arendal
Arendal, Norway
2
SSHF Kristiansand
Kristiansand, Norway, 4604